WORCESTER, Mass., Sept. 8, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that Anna Gluskin, the Company’s President & Chief Executive Officer, will present at the Rodman & Renshaw Annual Global Investment Conference on September 10, 2009.
